CD40 and non-Hodgkin lymphoma: In contrast, CD40 is highly expressed by B cell malignancies including non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL) and myeloma, and in that case, it promotes proliferation and inhibits the apoptosis of malignant B cells (73).